Product Information
URO-PAIN DUAL 162-162.5 MG TAB is a generic product labeled by Rising Pharma Holdings Inc., priced at $0.1759 per EA under NDC 57237033242. Its NADAC has been published 118 times since Jul 3, 2024.
Strength
162; 162.5 mg/1; mg/1
Manufacturer
Rising Pharma Holdings Inc.NDC
57237033242
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
METHENAMINE; SODIUM SALICYLATEApproval Type
Unapproved
On Market Since
12/6/2023
Price Statistics
The NADAC for URO-PAIN DUAL 162-162.5 MG TAB has been published 118 times since Jul 3, 2024, and over the history we have for it it has risen 55.8%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.1759 per EA |
|---|---|
| All-time high | $0.1796 (Jul 15, 2026) |
| All-time low | $0.1027 (Jul 17, 2024) |
| 52-week high | $0.1796 |
| 52-week low | $0.1663 |
| Median price | $0.1666 |
| Average price | $0.1588 |
| Largest weekly change | +16.8% (Nov 20, 2024) |
| Weeks tracked | 118 |
| Tracking since | Jul 3, 2024 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the Methenamine, Sodium salicylate market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Rising Pharma Holdings Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Methenamine, Sodium salicylate market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of URO-PAIN DUAL 162-162.5 MG TAB?
The current National Average Drug Acquisition Cost (NADAC) for URO-PAIN DUAL 162-162.5 MG TAB, manufactured by Rising Pharma Holdings Inc., is $0.1759 per EA (NDC 57237033242), effective Sep 30, 2026.
How has the price of URO-PAIN DUAL 162-162.5 MG TAB changed over time?
Over the history we have for it, the NADAC for URO-PAIN DUAL 162-162.5 MG TAB has risen 55.8%. It has been tracked across 118 weekly CMS publications since Jul 3, 2024.
What are the highest and lowest recorded NADAC prices for URO-PAIN DUAL 162-162.5 MG TAB?
Since Jul 3, 2024, the NADAC for URO-PAIN DUAL 162-162.5 MG TAB has ranged from a low of $0.1027 (Jul 17, 2024) to a high of $0.1796 (Jul 15, 2026), with a median of $0.1666 per EA.
Are there cheaper alternatives to URO-PAIN DUAL 162-162.5 MG TAB?
No other NADAC-published product currently shares the active ingredient and strength of URO-PAIN DUAL 162-162.5 MG TAB in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures URO-PAIN DUAL 162-162.5 MG TAB?
URO-PAIN DUAL 162-162.5 MG TAB (NDC 57237033242) is labeled by Rising Pharma Holdings Inc., and CMS classifies it as a generic product.